ARWR - ARROWHEAD PHARMACEUTICALS, INC.

QQQ $ 604.92 $ 3.94 (0.66 %)

DIA $ 461.73 $ 2.22 (0.48 %)

SPY $ 665.28 $ 3.75 (0.57 %)

TLT $ 91.09 $ -0.14 (-0.15 %)

GLD $ 391.28 $ -7.46 (-1.88 %)

Previous Close

$ 36.81

Open

$ 38.20

Bid

$ 36.50 x 170

Ask

$ 40.86 x 13

Day's Range

$ 36.57 - $ 39.36

52 Week Range

$ 9.57 - $ 40.29

Volume

1,877,816

Average Volume

Market Cap

5.09B

Beta (5Y Monthly)

$ 1.66

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-07-2025	06-30-2025	10-Q
2	05-12-2025	03-31-2025	10-Q
3	02-10-2025	12-31-2024	10-Q
4	11-26-2024	09-30-2024	10-K
5	08-08-2024	06-30-2024	10-Q
6	05-09-2024	03-31-2024	10-Q
7	02-06-2024	12-31-2023	10-Q
8	11-29-2023	09-30-2023	10-K
9	08-07-2023	06-30-2023	10-Q
10	05-02-2023	03-31-2023	10-Q
11	02-06-2023	12-31-2022	10-Q
12	11-28-2022	09-30-2022	10-K
13	08-04-2022	06-30-2022	10-Q
14	05-10-2022	03-31-2022	10-Q
15	02-02-2022	12-31-2021	10-Q
16	11-22-2021	09-30-2021	10-K
17	08-05-2021	06-30-2021	10-Q
18	05-04-2021	03-31-2021	10-Q
19	02-04-2021	12-31-2020	10-Q
20	11-23-2020	09-30-2020	10-K
21	08-05-2020	06-30-2020	10-Q
22	05-07-2020	03-31-2020	10-Q
23	02-05-2020	12-31-2019	10-Q
24	11-25-2019	09-30-2019	10-K
25	08-05-2019	06-30-2019	10-Q
26	05-08-2019	03-31-2019	10-Q
27	02-07-2019	12-31-2018	10-Q
28	12-11-2018	09-30-2018	10-K
29	08-07-2018	06-30-2018	10-Q
30	05-08-2018	03-31-2018	10-Q
31	02-09-2018	12-31-2017	10-Q
32	12-12-2017	09-30-2017	10-K
33	08-03-2017	06-30-2017	10-Q
34	05-03-2017	03-31-2017	10-Q
35	02-06-2017	12-31-2016	10-Q
36	12-14-2016	09-30-2016	10-K
37	08-09-2016	06-30-2016	10-Q
38	05-10-2016	03-31-2016	10-Q
39	02-09-2016	12-31-2015	10-Q
40	12-14-2015	09-30-2015	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Reiterates Buy on Arro...
10/08/2025 10:20:12

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Arrowhead Pharma (NASDAQ:ARWR) with a Buy and maintains $80 p...

Arrowhead Pharmaceuticals Files To Begin P...
10/07/2025 11:34:04

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today announced that it has filed a request for regulatory clearance to initiate ...

4-biotechnology-stocks-that-outshine-in-momentum-amid-strong-technicals

4 Biotechnology Stocks That Outshine In Mo...
09/29/2025 11:11:04

Four biotechnology stocks have surged into the top 10th percentile for momentum ranking, demonstrating remarkable week-on-week ...

Arrowhead Sues Ionis Seeking Declaratory J...
09/11/2025 11:31:48

Arrowhead Pharma Files Request For Regulat...
09/10/2025 11:31:54

- In preclinical studies presented today at the RNA Leaders USA Congress 2025, investigational ARO-MAPT demonstrated potent an...

HC Wainwright & Co. Reiterates Buy on Arro...
09/02/2025 16:05:27

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Arrowhead Pharma (NASDAQ:ARWR) with a Buy and maintains $80 p...

air-lease-ionis-pharmaceuticals-arrowhead-pharmaceuticals-and-other-big-stocks-moving-higher-on-tuesday

Air Lease, Ionis Pharmaceuticals, Arrowhea...
09/02/2025 14:41:45

Arrowhead Pharmaceuticals Inks Global Lice...
09/02/2025 11:32:42

Upon closing, Arrowhead will receive an upfront payment of $200 millionNovartis will receive an exclusive worldwide license to ...

Arrowhead Receives $100M Milestone From Sa...
08/13/2025 20:30:04

- Arrowhead has elected to receive approximately $50 million worth of Arrowhead common stock from Sarepta, which will be placed...

Chardan Capital Maintains Buy on Arrowhead...
08/11/2025 11:42:35

Chardan Capital analyst Keay Nakae maintains Arrowhead Pharma (NASDAQ:ARWR) with a Buy and maintains $60 price target.

RBC Capital Maintains Outperform on Arrowh...
08/08/2025 17:20:57

RBC Capital analyst Luca Issi maintains Arrowhead Pharma (NASDAQ:ARWR) with a Outperform and lowers the price target from $4...

Arrowhead Pharma Q3 EPS $(1.26) Misses $(0...
08/07/2025 20:04:13

Arrowhead Pharma (NASDAQ:ARWR) reported quarterly losses of $(1.26) per share which missed the analyst consensus estimate of $(...

Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

Sanofi To Acquire Rights To Develop, Comme...
08/01/2025 10:42:37

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today announced the signing of an asset purchase agreement between Sanofi and Vis...

sarepta-therapeutics-surges-over-40-in-tuesday-pre-market-whats-going-on

Sarepta Therapeutics Surges Over 40% In Tu...
07/29/2025 09:41:32

Stock of Sarepta Therapeutics Inc. (NASDAQ: SRPT) surged 38.89% in Tuesday pre-market following the U.S. Food and Drug Administ...

fda-probes-death-of-8-year-old-who-received-sareptas-elevidys

FDA Probes Death Of 8-Year-Old Who Receive...
07/28/2025 12:48:23

FDA probes Elevidys after an 8-year-old's death in Brazil; Sarepta and Roche say the death was unrelated to gene therapy tr...

Arrowhead Pharmaceuticals Earns $100M Mile...
07/28/2025 11:37:03

Arrowhead currently expects to achieve the second enrollment target by the end of 2025, which would trigger an additional $200 ...

Arrowhead Scores $100M From Sarepta After ...
07/28/2025 11:35:43

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today announced that it has earned a $100 million milestone payment from Sarepta ...

sarepta-gets-thumbs-down-from-regulators-regarding-elevidys-gene-therapy

Sarepta Gets Thumbs Down From Regulators R...
07/25/2025 15:09:35

Sarepta and Roche face a regulatory setback as the EMA's CHMP issues a negative opinion on Elevidys for Duchenne muscular d...

ge-vernova-posts-better-than-expected-earnings-joins-thermo-fisher-scientific-lennox-international-general-dynamics-and-other-big-stocks-moving-higher-on-wednesday

GE Vernova Posts Better-Than-Expected Earn...
07/23/2025 15:00:07